	Label	Description
	G43417UB Compound (Entity type)	type="BaseComposition" mass="383.142760805" permass="495.267961365" monosaccharides="2" is_motif="Fa...
	G37399XV Compound (Entity type)	type="Composition" mass="1728.60821665" permass="2163.09336882" monosaccharides="9" is_motif="False"...
	G60923RB Compound (Entity type)	type="BaseComposition" mass="1932.70799036" permass="2395.22444267" monosaccharides="11" is_motif="F...
	G87051GH Compound (Entity type)	type="BaseComposition" mass="2078.76589923" permass="2569.31365168" monosaccharides="12" is_motif="F...
	G41126SR Compound (Entity type)	type="BaseComposition" mass="2443.89809534" permass="3018.53974821" monosaccharides="14" is_motif="F...
	G26271XI Compound (Entity type)	type="BaseComposition" mass="2589.95600421" permass="3192.62895721" monosaccharides="15" is_motif="F...
	p05154-1 262asn 262asn defined go:0006486 go:0006487 Post Translational Modification (Entity type)	A Post Translational Modification
	IPSP HUMAN Protein (Entity type)	Plasma serine protease inhibitor (precursor)
	p05154-1 39thr 39thr defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	p05154-1 30arg 45arg range go:0006486 Post Translational Modification (Entity type)	A Post Translational Modification

G43417UB

type="BaseComposition" mass="383.142760805" permass="495.267961365" monosaccharides="2" is_motif="Fa...

G37399XV

type="Composition" mass="1728.60821665" permass="2163.09336882" monosaccharides="9" is_motif="False"...

G60923RB

type="BaseComposition" mass="1932.70799036" permass="2395.22444267" monosaccharides="11" is_motif="F...

G87051GH

type="BaseComposition" mass="2078.76589923" permass="2569.31365168" monosaccharides="12" is_motif="F...

G41126SR

type="BaseComposition" mass="2443.89809534" permass="3018.53974821" monosaccharides="14" is_motif="F...

G26271XI

type="BaseComposition" mass="2589.95600421" permass="3192.62895721" monosaccharides="15" is_motif="F...

p05154-1 262asn 262asn defined go:0006486 go:0006487

A Post Translational Modification

IPSP HUMAN

Plasma serine protease inhibitor (precursor)

p05154-1 39thr 39thr defined go:0006486 go:0006493

A Post Translational Modification

p05154-1 30arg 45arg range go:0006486

A Post Translational Modification

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.